Testosterone 45802-0366-65
- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Dosage Form
- Gel
- Route
- Topical
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- June 6, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA205781
Active Ingredients
| Ingredient | Strength |
|---|---|
| Testosterone | 40.5 mg/2.5g |
Drug Class
Androgen [EPC]Androgen Receptor Agonists [MoA]Androgen [EPC]
Selected Package
45802-0366-65Selected30 PACKET in 1 CARTON (45802-366-65) / 2.5 g in 1 PACKET (45802-366-02)